RECURRENT VULVAR CANCER
Clinical trials for RECURRENT VULVAR CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT VULVAR CANCER trials appear
Sign up with your email to follow new studies for RECURRENT VULVAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo offers hope for Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis study tests whether two drugs, pembrolizumab and lenvatinib, can shrink or control advanced vulvar cancer that has returned or spread and cannot be treated with surgery or radiation. About 42 women with this type of cancer will receive the drug combination. The goal is to se…
Matched conditions: RECURRENT VULVAR CANCER
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
Electric pulses plus chemo could spare women from mutilating surgery
Disease control Recruiting nowThis study tests a treatment called electrochemotherapy for women whose vulvar cancer has come back. It combines a chemotherapy drug (bleomycin) with short electric pulses to help the drug enter cancer cells more effectively. The goal is to shrink tumors and reduce the need for e…
Matched conditions: RECURRENT VULVAR CANCER
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated May 22, 2026 13:51 UTC